Incyte (INCY) had the highest return in 2009 by a US stock in the Biotechnology Industry and the S&P 500 (GSPC), returning 139.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Incyte (INCY) | 2009 | 139.74% |
Vertex Pharmaceuticals (VRTX) | 2009 | 41.54% |
Regeneron Pharmaceuticals (REGN) | 2009 | 31.27% |
Biogen (BIIB) | 2009 | 12.66% |
Amgen (AMGN) | 2009 | -3.45% |
Gilead Sciences (GILD) | 2009 | -14.99% |
